Comparative Clinical Pathology

, Volume 23, Issue 4, pp 1087–1094

Immunomodulatory effect of Kalpaamruthaa on 7,12-dimethyl benz(a)anthracene-induced mammary carcinoma studied in rats

  • Vijayakanth Dharmendra
  • Shanthi Palanivelu
  • Sachdanandam Panchanadham
Original Article


Kapaamruthaa is a modified Siddha preparation prepared in our laboratory. It has been proven to have therapeutic effect against arthritis and liver cancer. The present study was carried out to bring about the protective effect of Kalpaamruthaa on experimental mammary carcinoma in rats with special reference to cytokines, carcinoembryonic antigen (CEA), carbohydrate antigen 15–3 (CA 15–3), immunoglobulin levels, and glycoprotein components. Breast cancer was induced in rats by administering 7,12-dimethylbenz(a)anthracene (DMBA) orally (25 mg/rat) as a single dose. After 90 days of induction, Semecarpus anacardium Linn. (200 mg/kg body weight) and Kalpaamruthaa (KA) (300 mg/kg body weight) were administered for 14 days, by gastric intubation. In mammary carcinoma-bearing rats, the levels of interleukin-6, interleukin-8, and tumor necrosis factor-α were significantly increased (p < 0.001) in serum when compared to control rats. The levels of CEA and CA 15–3 were found to be significantly increased (p < 0.001) in mammary carcinoma-bearing rats. The levels of IgG and IgM were significantly decreased (p < 0.001) whereas IgA levels were significantly increased (p < 0.001) in mammary carcinoma-bearing rats. The levels of glycoprotein components namely hexose, hexosamine, and sialic acid were significantly (p < 0.001) increased in the spleen and thymus of the mammary carcinoma-bearing (group II) rats when compared to control rats. Treatment with KA significantly altered the levels of cytokines, CEA, CA 15–3, immunoglobulins, and glycoprotein components to near normal levels when compared to breast cancer-induced rats. The present study suggests the therapeutic effect of KA in DMBA-induced mammary carcinoma in rats.


Kalpaamruthaa DMBA Mammary carcinoma Cytokines Tumor markers Immunoglobulins 


  1. Alexander FE, Roberts MM (1987) The menopause and breast cancer. J Epidemiol Community Health 41:94–100PubMedCentralPubMedCrossRefGoogle Scholar
  2. Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H (1993) Anti-inflammatory activities of Emblica officinalis Gaertn. Leaf extracts. J Pharm Pharmacol 45:581–584PubMedCrossRefGoogle Scholar
  3. Bendich A (1997) Vitamin C safety in humans. In: Packer L, Fuchs J (eds) Vitamin C in health and disease. Marcel-Dekker, New York, pp 367–379Google Scholar
  4. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early stage breast cancer. N Engl J Med 340:1733–1739PubMedCrossRefGoogle Scholar
  5. Chan GC, Cheung KW, Sze DM (2012) The immunomodulatory and anticancer properties of propolis. Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8322-2 Google Scholar
  6. Chandy KG, Huebscher SG, Elias E, Berg J, Khan M, Burnett D (1983) Dual role of the liver in regulating polymeric IgA in man: studies on patients with liver diseases. Clin Exp Immunol 52:207–18PubMedCentralPubMedGoogle Scholar
  7. Culig Z, Steiner H, Bartsch G, Hobisch A (2005) Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95:497–505PubMedCrossRefGoogle Scholar
  8. Ehrke MJ (2003) Immunomodulation in cancer therapeutics. Int Immunopharmacol 3:1105–1119PubMedCrossRefGoogle Scholar
  9. Elangovan V, Nalini R, Balasubramanian S, Sekar N, Govindasamy S (1994) Studies on the anti-proliferative effect of some naturally occurring bioflavonoidal compounds against human carcinoma of larynx and Sarcoma-180 cell lines. Indian J Pharmacol 26:266–269Google Scholar
  10. Formulary A (1972) Formulary of Siddha Medicine. 2nd edn. Indian Medicine Practitioners Cooperative Pharmacy and Stores Ltd, Madras, p 197Google Scholar
  11. Friedrich A, Walther E, Bomski B, Glass W (1984) Simultaneous studies of granulocyte phagocytosis, serum immunoglobulins, acute phase proteins and 3d complement component in patients with malignant tumors. Arch Geschwulstforsch 54:137–152PubMedGoogle Scholar
  12. Hayes D, Zuwarsky JV, Kufe D (1986) Comparison of circulating CA 15.3 and CEA in patients with breast cancer. J Clin Oncol 4:1542–1550PubMedGoogle Scholar
  13. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334:297–314PubMedCentralPubMedGoogle Scholar
  14. Honma S, Shimodaira K, Shimizu Y et al (2002) The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J 49:371–7PubMedCrossRefGoogle Scholar
  15. Huang CF, Lin SS, Liao PH, Young SC, Yang CC (2008) The immunopharmaceutical effects and mechanisms of herb medicine. Cell Mol Immunol 5:23–31PubMedCrossRefGoogle Scholar
  16. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics 2008. CA Cancer J Clin 58:71–96PubMedCrossRefGoogle Scholar
  17. Katz AE (1983) Immunobiologic staging of patients with carcinoma of the hand and neck. Laryngoscope 93:445–463PubMedGoogle Scholar
  18. Khan HB, Vinayagam KS, Sekar A, Palanivelu S, Panchanatham S (2012) Antidiabetic and antioxidant effect of Semecarpus anacardium Linn. nut milk extract in a high fat diet STZ-induced type 2 diabetic rat model. J Diet Suppl 9(1):19–33PubMedCrossRefGoogle Scholar
  19. Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchanatham S (2013) Anti-inflammatory and anti-hyperlipidemic effect of Semecarpus anacardium in a high fat diet: STZ-induced type 2 diabetic rat model. Inflammopharmacology 21(1):37–46. doi:10.1007/s10787-011-0109-1 PubMedCrossRefGoogle Scholar
  20. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ (2001) Expression of interleukin-8 correlates with angiogenesis, tumourigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 3:33–42PubMedCrossRefGoogle Scholar
  21. Kortze JP, Mathews MJ, Klerk WA (1974) Effect of ascorbic acid on lipoprotein lipase activity. S Afr Med J 48:511–514Google Scholar
  22. Lamoureux G, Mandeville R, Poisson R, Legault-Poisson S, Jolicoeur R (1982) Biologic markers and breast cancer. A multiparametric study increased serum protein levels. Cancer 49:502–512PubMedCrossRefGoogle Scholar
  23. Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik N-S et al (2010) Is breast cancer the same disease in Asian and Western countries? World J Surg 34:2308–2324PubMedCentralPubMedCrossRefGoogle Scholar
  24. Lowry OH, Rosenbrough NJ, Farr AI, Randall RJ (1951) Protein determination using Folin Ciocalteu reagent. Ind Vet J 193:265–275Google Scholar
  25. Micksche M, Luger T, Mchelica W, Tatra G (1978) Investigations on general immune reactivity in untreated cervical cancer patients. Oncology 35:206–209PubMedCrossRefGoogle Scholar
  26. Murthy SSN (1992) New biflavanoid from Semecarpus anacardium Linn. Clin Acta Turcica 20:33–37Google Scholar
  27. Niebes P (1972) Determination of enzymes and degradation products of glycosaminoglycans. Clin Chim Acta 42:399–408CrossRefGoogle Scholar
  28. O'Kennedy R, Berns G, Moran E, Smyth H, Carroll K, Thornes RD (1991) A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett 58:91–100PubMedCrossRefGoogle Scholar
  29. Purohit A, Newman SP, Reed MJ (2002) The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4:65–69PubMedCentralPubMedCrossRefGoogle Scholar
  30. Ramprasath VR, Shanthi P, Sachdanandam P (2005) Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on the components of immune system in adjuvant arthritis. Vasc Pharmacol 42:179–186CrossRefGoogle Scholar
  31. Roberts MM, Bathgate EM, Stevenson A (1975) Serum immunoglobulin levels in patients with breast cancer. Cancer 36:221–4PubMedCrossRefGoogle Scholar
  32. Satpathy PK, Dutta NK, Mishra PR, Kar BC (1996) Glutaraldehyde coagulation test: standard curve and its applications to detect gammaglobulin level in kids. Ind Vet J 73:257–260Google Scholar
  33. Sell S (1990) Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol 21:1003–1019PubMedCrossRefGoogle Scholar
  34. Selvam S, Nagini S (1995) Administration of the plasticizer di(2-ethylhexyl) phthalate alters glycoconjugate profile. Indian J Physiol Pharmacol 39:252–254PubMedGoogle Scholar
  35. Sheen-Chen SM, Chen WJ, Eng HL, Chou FF (1997) Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43:211–215PubMedCrossRefGoogle Scholar
  36. Sternberg Z, Chadha K, Lieberman A, Drake A, Hojnacki D, Weinstock-Guttman B, Munschauer F (2009) Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β. J Neuroinflammation 6:28PubMedCentralPubMedCrossRefGoogle Scholar
  37. Sujatha V, Sachdanandam P (2002) Recuperative effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother Res 16:S14–S18PubMedCrossRefGoogle Scholar
  38. Szlosarek PW, Balkwill FR (2003) Tumor necrosis factor a: a potential target for the therapy of solid tumors. Lancet Oncol 4:565–573PubMedCrossRefGoogle Scholar
  39. Tennant BH, Baldwin RK, Braun ML, Norcross SM (1979) Use of the glutaraldehyde coagulation test for the detection of hypogamma-globulinemia in neonatal calves. Am J Vet Med 174:848–53Google Scholar
  40. Thompson DK, Haddow JE, Smith DE, Ritchie RF (1981) Serum protein changes in women with early breast cancer. Cancer 48:793–798PubMedCrossRefGoogle Scholar
  41. Thompson JA, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5:344–66PubMedCrossRefGoogle Scholar
  42. Veena K, Shanthi P, Sachdanandam P (2006) Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components lysosomal and marker enzymes. Biol Pharm Bull 29:565–569PubMedCrossRefGoogle Scholar
  43. Wagner WD (1979) More sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem 94:394–397PubMedCrossRefGoogle Scholar
  44. Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971–1975PubMedGoogle Scholar
  45. Whiteside TL (2006) Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 16:3–15PubMedCrossRefGoogle Scholar
  46. Yang CS, Landau JM, Huang MT, Newmark HL (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381–406PubMedCrossRefGoogle Scholar
  47. Zamcheck N, Martin EW (1981) Factors controlling the circulating CEA levels in pancreatic cancer, some clinical correlations. Cancer 47:1620–1627PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Vijayakanth Dharmendra
    • 1
  • Shanthi Palanivelu
    • 2
  • Sachdanandam Panchanadham
    • 1
  1. 1.Department of Medical Biochemistry, Dr A.L.M. P-G. I.B.M.S.University of MadrasChennaiIndia
  2. 2.Department of Pathology, Dr A.L.M. P-G. I.B.M.S.University of MadrasChennaiIndia

Personalised recommendations